Literature DB >> 27397495

Synthesis and biological evaluation of N(9)-substituted harmine derivatives as potential anticancer agents.

Hongtao Du1, Shan Tian2, Juncheng Chen3, Hongling Gu4, Na Li5, Junru Wang6.   

Abstract

A series of N(9)-substituted harmine derivatives were synthesized and evaluated for their anticancer activity on a panel of cancer cell lines, their apoptosis induction and their cell cycle effects. The results showed that N(9)-substituted harmine derivatives had anticancer effects. In particular, N(9)-haloalkyl derivatives 9a-9c and N(9)-acyl harmine derivatives 11c and 11d, with IC50 values less than 1μM, were more potent than doxorubicin against A-549 and/or MCF-7 cell lines. Moreover, structure-activity relationships (SARs) indicated that introducing a haloalkyl or benzenesulfonyl group in the N(9)-position of harmine could significantly increase the anticancer activity. The most active compound (11d) caused cell cycle arrest in the G2/M phase, and induced cell apoptosis in a dose-dependent manner.
Copyright © 2016. Published by Elsevier Ltd.

Entities:  

Keywords:  Anticancer activities; Apoptosis; Cell cycle arrest; Harmine derivatives; Structure–activity relationships (SARs)

Mesh:

Substances:

Year:  2016        PMID: 27397495     DOI: 10.1016/j.bmcl.2016.06.087

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

1.  Harmines inhibit cancer cell growth through coordinated activation of apoptosis and inhibition of autophagy.

Authors:  Xinran Geng; Yichang Ren; Fangfang Wang; Danmei Tian; Xinsheng Yao; Youwei Zhang; Jinshan Tang
Journal:  Biochem Biophys Res Commun       Date:  2018-03-01       Impact factor: 3.575

2.  Synthesis and biological evaluation of novel N9-heterobivalent β-carbolines as angiogenesis inhibitors.

Authors:  Liang Guo; Qin Ma; Wei Chen; Wenxi Fan; Jie Zhang; Bin Dai
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

3.  Synthesis and In Vitro Antitumor Activity of Novel Bivalent β-Carboline-3-carboxylic Acid Derivatives with DNA as a Potential Target.

Authors:  Hongling Gu; Na Li; Jiangkun Dai; Yaxi Xi; Shijun Wang; Junru Wang
Journal:  Int J Mol Sci       Date:  2018-10-15       Impact factor: 5.923

4.  Exploring Kinase Inhibition Properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine Derivatives.

Authors:  Yvonnick Loidreau; Carole Dubouilh-Benard; Marie-Renée Nourrisson; Nadège Loaëc; Laurent Meijer; Thierry Besson; Pascal Marchand
Journal:  Pharmaceuticals (Basel)       Date:  2020-05-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.